https://www.selleckchem.com/products/Y-27632.html
001). At 3-months there were reductions in severity of tricuspid regurgitation (TR) (p 0.001) and pulmonary artery systolic pressure (PASP) (49 ± 16 mmHg vs 36 ± 12 mmHg; p 0.001), and improvements in RV fractional area change (28 ± 7% vs 34 ± 9%, p0.001), tricuspid annular plane systolic excursion (TAPSE) (1.0 ± 0.3 vs 1.5 ± 0.5cm, p = 0.03), and RV free wall longitudinal strain (-14.2±5.0 vs -17.6±7.3, p = 0.05). Transapical TMVI results in significant improvement of RV function that is sustained to 3-months as evidenced
Like
Comment
Share
